Literature DB >> 3025081

EB virus induction is associated with B-cell maturation.

D H Crawford, I Ando.   

Abstract

EB virus genome-carrying B-cell lines have been double-stained for B-cell activation or maturation antigens and viral antigens using indirect immunofluorescence. The vast majority of cells express activation antigens, whereas the plasma cell antigen PC1 is present on only a few cells. Staining for this antigen doubles with staining for EB viral capsid antigen. Thus it marks cells in the virus replicative cycle, and these cells are negative for the EB virus nuclear antigen EBNA. We suggest that within EB virus genome-carrying B-cell lines the maturation of a few cells to the stage of expression of plasma-cell markers leads to the loss of EBNA expression and consequent loss of the immortalized state of the cell. This would allow completion of the lytic cycle with the production of virus particles and cell death. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025081      PMCID: PMC1453205     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.

Authors:  W C Summers; G Klein
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

2.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

3.  Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.

Authors:  T B Sculley; D G Sculley; J H Pope
Journal:  J Gen Virol       Date:  1985-05       Impact factor: 3.891

4.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

5.  Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy.

Authors:  H zur Hausen; W Henle; K Hummeler; V Diehl; G Henle
Journal:  J Virol       Date:  1967-08       Impact factor: 5.103

6.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

9.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  41 in total

1.  The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression.

Authors:  Henri Gruffat; Faouzi Kadjouf; Bernard Mariamé; Evelyne Manet
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

2.  Secreted Oral Epithelial Cell Membrane Vesicles Induce Epstein-Barr Virus Reactivation in Latently Infected B Cells.

Authors:  Zhen Lin; Kenneth Swan; Xin Zhang; Subing Cao; Zoe Brett; Stacy Drury; Michael J Strong; Claire Fewell; Adriane Puetter; Xia Wang; MaryBeth Ferris; Deborah E Sullivan; Li Li; Erik K Flemington
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

3.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

4.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  The infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cells.

Authors:  Georg W Bornkamm; Uta Behrends; Josef Mautner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

6.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.

Authors:  C Meyers; T J Mayer; M A Ozbun
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

8.  Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4.

Authors:  Jian Zhu; Gangling Liao; Liang Shan; Jun Zhang; Mei-Ru Chen; Gary S Hayward; S Diane Hayward; Prashant Desai; Heng Zhu
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

Review 9.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

Review 10.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.